Clinicopathological Aspects and Inflammation-Immune Markers in Alcohol and/or Hepatitis C Virus-Induced Hepatocellular Carcinoma Patients Treated With Sorafenib.
Thiago Alexandre Martins PintoHelena Paes Almeida SaitoCarolina Lopes NouraniElaine Cristina AtaideIlka Fatima Santana Ferreira BoinGustavo Jacob LourencoCarmen Silvia Passos LimaPublished in: Gastroenterology research (2024)
AFP level and Child-Pugh score act as independent prognostic factors in patients with alcohol and/or HCV-induced HCC treated with sorafenib, but markers of chronic inflammation/immune homeostasis seem not to alter the outcome of patients with HCC induced by alcohol and/or HCV.